Physician

Christopher J Charbonnet, M.D.

According to 2025 Medicare claims, Christopher Charbonnet, M.D. (NPI: 1225049968) practices interventional pain management (ipm) in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is CHRISTOPHER J. CHARBONNET, M.D., A PROFESSIONAL CORPORATION (NPI: 1679785695) and primary practice location at 91206-4163.

Charbonnet's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 794 traditional Medicare patients, billed 6,779 HCPCS/CPT codes, and received $425,730 in Medicare payments. The top billing code was 64483 (Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level). Part D data shows 5,507 prescription claims across 532 beneficiaries totaling $219,293 in drug costs, led by Belbuca (Buprenorphine Hcl). Open Payments data shows 62 records totaling $1,648. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $327,348 to $425,730. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	849	4,065	$327,348
2016	797	4,037	$322,709
2017	773	3,466	$276,507
2018	806	4,095	$303,852
2019	868	4,647	$376,220
2020	732	4,499	$371,079
2021	811	4,672	$435,852
2022	765	4,562	$422,648
2023	764	5,142	$443,062
2024	794	6,779	$425,730

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	501	4,380	$337,343
2016	539	4,727	$351,924
2017	517	5,023	$315,204
2018	523	4,897	$317,398
2019	561	5,580	$334,843
2020	524	5,700	$281,649
2021	524	5,767	$293,108
2022	574	6,000	$324,136
2023	549	5,822	$310,258
2024	532	5,507	$219,293

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	208	267	$196
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	412	1,406	$105
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	207	207	$76
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	255	470	$58
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	198	333	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Belbuca	Buprenorphine Hcl	58	1,740	$39,769
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	1,464	41,955	$33,733
Buprenorphine	Buprenorphine	39	1,092	$12,275
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	414	11,979	$11,977
Oxycontin	Oxycodone Hcl	17	510	$9,071

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	62	$1,648	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher J. Charbonnet, M.D.?

Tedicare shows public-source Medicare data for Christopher J. Charbonnet, M.D. (NPI 1225049968), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher J. Charbonnet, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Christopher J. Charbonnet, M.D.?

Christopher J. Charbonnet, M.D. is linked to CHRISTOPHER J. CHARBONNET, M.D., A PROFESSIONAL CORPORATION (billing NPI 1679785695) in the available physician profile data.

Does Christopher J. Charbonnet, M.D. have Open Payments data?

Christopher J. Charbonnet, M.D. has 62 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.